Cargando…
Fighting the Antibiotic Crisis: Flavonoids as Promising Antibacterial Drugs Against Helicobacter pylori Infection
Over half of the world’s population is estimated to be infected with Helicobacter pylori. Chronic infection with this microbial class I carcinogen is considered the most important risk factor for developing gastric cancer. The increasing antimicrobial resistance to first-line antibiotics mainly caus...
Autores principales: | González, Andrés, Casado, Javier, Lanas, Ángel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329489/ https://www.ncbi.nlm.nih.gov/pubmed/34354964 http://dx.doi.org/10.3389/fcimb.2021.709749 |
Ejemplares similares
-
Two-component regulatory systems in Helicobacter pylori and Campylobacter jejuni: Attractive targets for novel antibacterial drugs
por: Casado, Javier, et al.
Publicado: (2022) -
Editorial: Helicobacter pylori and its mechanisms of antibiotic survival
por: Krzyżek, Paweł, et al.
Publicado: (2023) -
1,4-Dihydropyridine as a Promising Scaffold for Novel Antimicrobials Against Helicobacter pylori
por: González, Andrés, et al.
Publicado: (2022) -
Current and future perspectives for Helicobacter pylori treatment and management: From antibiotics to probiotics
por: Liang, Bing, et al.
Publicado: (2022) -
Editorial: Helicobacter pylori infection and antibiotic resistance: clinical, translational and experimental studies
por: Yadegar, Abbas, et al.
Publicado: (2023)